a pioneering startup in the field of ophthalmic solutions, in a merger transaction with the renowned medical device company, Alcon, in a US$460,000,000 transaction. This deal which is one of the most substantial biomed transactions in Israel in recent times, includes an immediate payment of $81,000,000 and an additional $385,000,000 in milestone payments.
Menu
